Sign in

CIK 0001160308

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841318182
Phone
+51 285113796
Business address
6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
Former names
Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
  1. 4 Open-market buy Director bought 54,890 shares at an average $1.50 ($82,105)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Exercise or conversion Director acquired 1,172 shares (option exercise)
  8. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 325,000 shares (grant or award)
  9. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 100,000 shares (grant or award)
  10. 4 Exercise or conversion Director acquired 1,172 shares (option exercise)
  11. 4 Open-market buy Director bought 20,105 shares at an average $1.43 ($28,652)
  12. 4 Grant or award Chief Medical Officer acquired 150,000 shares (grant or award)
  13. 4 Open-market buy Director bought 50,005 shares at an average $1.37 ($68,441)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy Director bought 135,000 shares at an average $1.39 ($187,093)
  16. 4 Open-market buy Director bought 8,000 shares at an average $1.45 ($11,562)
  17. 4 Open-market buy Director bought 32,000 shares at an average $1.40 ($44,722)
  18. 4 Open-market buy Director bought 100,000 shares at an average $1.42 ($141,932)
  19. 4 Open-market buy Director bought 100,000 shares at an average $1.38 ($138,380)
  20. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 62,318 shares (to pay taxes)

Page 5 of 22 · 436 filings